Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 3 | 2018 | 333 | 0.610 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 1541 | 0.390 |
Why?
|
| Radiosurgery | 3 | 2018 | 147 | 0.360 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 768 | 0.350 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 1018 | 0.320 |
Why?
|
| Neoplasms, Second Primary | 2 | 2018 | 149 | 0.240 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2025 | 37 | 0.230 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2025 | 189 | 0.210 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2025 | 238 | 0.210 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2018 | 1304 | 0.190 |
Why?
|
| Pulmonary Artery | 1 | 2025 | 463 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 623 | 0.180 |
Why?
|
| Hypertension, Pulmonary | 1 | 2025 | 463 | 0.170 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 79 | 0.130 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 1365 | 0.130 |
Why?
|
| Macaca mulatta | 1 | 2016 | 506 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 956 | 0.110 |
Why?
|
| Whole Genome Sequencing | 1 | 2016 | 327 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 7138 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 946 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5410 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2166 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2009 | 188 | 0.070 |
Why?
|
| Cell Lineage | 1 | 2009 | 358 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2025 | 2491 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2018 | 13027 | 0.070 |
Why?
|
| Vascular Remodeling | 1 | 2025 | 54 | 0.060 |
Why?
|
| Arterial Pressure | 1 | 2025 | 127 | 0.060 |
Why?
|
| Ventricular Function, Right | 1 | 2025 | 119 | 0.060 |
Why?
|
| Aged | 3 | 2018 | 21482 | 0.050 |
Why?
|
| Middle Aged | 3 | 2018 | 29021 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2025 | 3868 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2025 | 685 | 0.040 |
Why?
|
| Male | 4 | 2025 | 65014 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2025 | 3046 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4690 | 0.040 |
Why?
|
| Female | 4 | 2018 | 70787 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2511 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 6451 | 0.030 |
Why?
|
| Population Density | 1 | 2016 | 33 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2018 | 200 | 0.030 |
Why?
|
| Genetic Fitness | 1 | 2016 | 36 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 4758 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 2016 | 158 | 0.030 |
Why?
|
| Humans | 4 | 2025 | 132247 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 469 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2018 | 576 | 0.030 |
Why?
|
| Animals | 3 | 2025 | 34854 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 2196 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 700 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2025 | 4720 | 0.020 |
Why?
|
| Mice | 2 | 2025 | 18509 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2233 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2923 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 38 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2009 | 43 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5176 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2851 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 1734 | 0.010 |
Why?
|
| Asthma | 1 | 2009 | 773 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1965 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 17395 | 0.010 |
Why?
|